SecSonar.com

Heartflow, Inc. Common Stock (HTFL)

Heartflow, Inc. Common Stock at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Heartflow, Inc. Common Stock (HTFL) is a Medical - Healthcare Information Services company based in US with a market capitalization of $2.7B. Revenue grew 39.9% year-over-year and free cash flow was negative at -$59M. This page tracks HTFL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 626 employees · IPO Aug 7, 2025

Valuation

Valuation & price

$28.32 · as of May 17, 2026 · -29.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

9.08

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$39.31$30.05$20.79Aug 25Jan 26Jul 26Aug 8, 25$28.75Aug 11, 25$29.99Aug 13, 25$33.24Aug 15, 25$31.17Aug 19, 25$30.67Aug 21, 25$28.93Aug 25, 25$29.84Aug 27, 25$34.76Aug 29, 25$31.50Sep 2, 25$31.16Sep 4, 25$34.09Sep 8, 25$34.50Sep 10, 25$33.48Sep 12, 25$33.38Sep 16, 25$31.22Sep 18, 25$32.48Sep 22, 25$31.43Sep 24, 25$34.49Sep 25, 25$33.92Sep 29, 25$34.50Oct 1, 25$35.92Oct 3, 25$37.64Oct 7, 25$34.99Oct 9, 25$32.89Oct 13, 25$33.22Oct 15, 25$34.41Oct 16, 25$33.47Oct 20, 25$35.05Oct 22, 25$39.31Oct 24, 25$37.87Oct 28, 25$38.30Oct 30, 25$36.57Nov 3, 25$34.05Nov 5, 25$34.71Nov 7, 25$32.56Nov 10, 25$33.83Nov 12, 25$35.74Nov 14, 25$27.98Nov 18, 25$27.31Nov 20, 25$27.67Nov 24, 25$30.85Nov 26, 25$31.43Dec 1, 25$30.15Dec 2, 25$29.62Dec 4, 25$28.94Dec 8, 25$27.95Dec 10, 25$28.07Dec 12, 25$26.48Dec 16, 25$26.47Dec 18, 25$28.65Dec 22, 25$31.25Dec 24, 25$30.44Dec 26, 25$29.83Dec 30, 25$30.21Jan 2, 26$28.97Jan 6, 26$31.17Jan 8, 26$33.47Jan 12, 26$31.79Jan 14, 26$34.98Jan 16, 26$37.16Jan 21, 26$33.55Jan 22, 26$33.50Jan 26, 26$31.04Jan 28, 26$31.10Jan 30, 26$29.87Feb 3, 26$28.39Feb 5, 26$25.99Feb 9, 26$29.29Feb 11, 26$26.95Feb 12, 26$22.49Feb 17, 26$22.27Feb 19, 26$23.99Feb 23, 26$22.16Feb 25, 26$23.00Feb 27, 26$23.16Mar 3, 26$23.87Mar 5, 26$24.86Mar 9, 26$23.18Mar 10, 26$22.59Mar 12, 26$20.79Mar 16, 26$20.98Mar 18, 26$25.47Mar 20, 26$26.02Mar 24, 26$27.97Mar 26, 26$25.88Mar 30, 26$23.87Mar 31, 26$24.33Apr 2, 26$24.83Apr 7, 26$26.87Apr 9, 26$27.08Apr 13, 26$27.43Apr 15, 26$29.23Apr 17, 26$31.34Apr 21, 26$31.85Apr 23, 26$31.24Apr 24, 26$30.44Apr 28, 26$30.55Apr 30, 26$29.76May 4, 26$28.95May 6, 26$30.29May 8, 26$29.51May 12, 26$29.42May 14, 26$32.24May 15, 26$28.32May 19, 26$26.60May 21, 26$29.20May 26, 26$28.40May 28, 26$31.73Jun 1, 26$31.00Jun 3, 26$28.85Jun 5, 26$28.10Jun 9, 26$28.67Jun 10, 26$29.43Jun 12, 26$33.24Jun 16, 26$32.05Jun 18, 26$33.64Jun 23, 26$34.48Jun 25, 26$34.98Jun 29, 26$34.85Jul 2, 26$28.15
$20.4952-week range$39.91
Loading valuation history…

Fundamentals

Key fundamentals

$2.7B

Market cap

39.9%

Revenue growth (YoY)

76.8%

Gross margin

-$59M

Free cash flow (USD)

-$154.7M

Net debt

Net cash position

484.4%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2023 → 2025

FY 2023$87.2MFY 2024$125.8MFY 2025$176.0M
$87.2M$176M

Free cash flow by year

2023 → 2025

FY 2023$-82.5MFY 2024$-73.4MFY 2025$-59.0M
-$82.5M-$59M

Gross margin by year

2023 → 2025

FY 202366.6%FY 202475.1%FY 202576.8%
66.6%76.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.16)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $1.4M · 10b5-1 PlanFarquhar John C.M. · Director, Chief Executive Officer · $1.4MJun 26, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • Insider sellInsider Sell $643K · 10b5-1 PlanFarquhar John C.M. · Director, Chief Executive Officer · $643KJun 12, 2026Filing
  • Insider sellInsider Sell $261K · 10b5-1 PlanRogers Campbell · Chief Medical Officer · $261.3KMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • Insider sellInsider Sell $657K · 10b5-1 PlanFarquhar John C.M. · Director, Chief Executive Officer · $657KMay 13, 2026Filing
  • Insider sellInsider Sell $58.9MBain Capital Life Sciences Investors, LLC · 10% Owner · $58.9MApr 30, 2026Filing
  • Insider sellInsider Sell $603K · 10b5-1 PlanFarquhar John C.M. · Director, Chief Executive Officer · $602.9KApr 14, 2026Filing
  • Insider sellInsider Sell $1.6M · 10b5-1 PlanRogers Campbell · Chief Medical Officer · $1.6MApr 3, 2026Filing

Questions

Frequently asked questions

What is Heartflow, Inc. Common Stock's market cap?

Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $2.7B.

What is HTFL's P/E ratio?

A meaningful P/E ratio is not available for HTFL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HTFL's price-to-book (P/B) ratio?

HTFL trades at 9.08 times book value per share.

When did Heartflow, Inc. Common Stock last report earnings?

HTFL last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying HTFL stock?

SEC Form 4 filings show no open-market insider buys at Heartflow, Inc. Common Stock in the last 90 days (6 sells).

Same arena

Related companies in Medical - Healthcare Information Services

PRVA

Privia Health Group, Inc.

$2.7B

PGNY

Progyny, Inc.

$2B

OMCL

Omnicell, Inc.

$2B

TXG

10x Genomics, Inc.

$3.6B

WGS

GeneDx Holdings Corp.

$1.5B

DOCS

Doximity, Inc.

$4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.